Diagnostic and Therapeutic Trends in Alzheimer's Disease

Table of Contents

1. EXECUTIVE SUMMARY

Research Scope and Methodology

• Research Scope
• Research Methodology

Research Highlights

• Industry Overview and Key Trends
• Snapshot of Noteworthy Developments

2. TECHNOLOGY PRIMER

Alzheimer' s Disease (AD) Overview

• AD--A Century Old Pathology
• Theories in AD--The Role of Plaques and Tangles
• Disease Stages; Symptoms; and Statistics

Alzheimer' s Disease Diagnosis and Therapy Overview

• Diagnosis of AD
• Therapy Overview

3. TECHNOLOGY INTELLIGENCE IN THE AD SPACE

Novel Mechanism of Action Drugs--Corporate Advancements

• A ‘Food Drug' a Day May Keep Alzheimer' s disease Away
• Protecting Neurons by Targeting Cells' Powerhouses
• Novel Neuroprotective Therapeutic Agents May Soon Validate ' Tau Theory' in Alzheimer' s
• Steroids Mediated Clearance of Amyloid Plaques in Alzheimer' s
• Improving Memory by Amplifying a Novel Receptor Implicated in Neurotransmission
• A Broad Portfolio of Novel Drugs in the Pipeline for Alzheimer' s

AD Therapeutics--Academic Research Highlights

• Study Identifies Molecule Involved in Beta-Amyloid Induced Neuron Death
• Vaccine for Alzheimer' s Triggers a Safe Immune Response and Clears Amyloid Plaques in a Mice Study

Advances in AD Diagnosis--Corporate and Academic Efforts

• Alzheimer' s Diagnosis Made Simple and Safe with a Novel Blood Test
• Advances in In Vitro Detection of the Amyloid Plaques in Alzheimer' s
• Computers to the Rescue - A Novel Approach to Early AD Diagnosis
• Imaging Studies Reveal a Functional Maker Implicated in Early Alzheimer' s Disease

4. TECHNOLOGY ADOPTION FACTOR ANALYSIS

Force-Field Analysis

• The Driving Forces
• The Restraining Forces and Challenges

Strategic Evaluation of the Competitive Environment

• A Strategic Evaluation of AD Medication Space--SWOT Analysis
• Strategic Assessment of Competitive Landscape and Attractiveness of AD Therapeutics Sector--World

Current and FutureTrends; Industry Roadmap; and Strategic Recommendations (Analyst' s Perspectives)

• Roadmap of Diagnostic and Therapeutic Trends in AD Sector
• Strategic Recommendations for Existing Symptomatic Drugs
• Strategic Recommendations for Disease Modifying Drugs

5. INTELLECTUAL PROPERTY (IP) SCENARIO; KEY CONTACTS

The IP Scenario

• Alzheimer' s Disease Therapeutics--Key Patents
• Alzheimer' s Disease Diagnostics--Key Patents

Key Contacts

• Key Corporate Contacts
• Key Academic Contacts

6. DECISION SUPPORT DATABASE TABLES

Database Tables

• Total Healthcare Expenditure--World (2002 to 2012)
• Pharmaceutical R&D Expenditure--World (2002 to 2012)
• Number of Physicians--World (2002 to 2012)
• Number of Hospitals--World (2002 to 2012)
• Number of Nurses--World (2002 to 2012)